Cyanine5 NHS ester minimal dye

NHS esters Protein labeling Cyanine5
Cat. # Quantity Price Lead time
1C041 5 nmol $110 in stock
2C041 10 nmol $175 in stock
3C041 25 nmol $265 in stock
Bulk inquiry
Found better price? Let us know and we will propose the way forward!

Cyanine5 minimal dye for protein labeling, an analog of Cy5® minimal dye.

This reagent is specially quantified for the use in 2D proteomics. Each package contains specified amount of NHS ester with quantity variation within 10%.

Cyanine5 NHS ester minimal dye, 3C041
Cyanine5 NHS ester minimal dye, 3C041
Cyanine5 NHS ester minimal dye, 3C041

Customers also purchased with this product

BDP® 558/568 NHS ester

BDP 558/568 is a fluorophore for the yellow region of the spectrum. Like other BDP dyes, this fluorophore has high fluorescence quantum yield, brightness, and photostability.

Propidium Iodide

Propidium iodide is a membrane-impermeable intercalating DNA dye for staining nuclei of death cells.

sulfo-Cyanine5.5 NHS ester

Water soluble, sulfonated, far-red sulfo-Cyanine5.5 dye in the form of NHS ester.

General properties

Appearance: dark blue solid
Mass spec M+ increment: 580.73
Molecular weight: 667.54
Molecular formula: C36H42BF4N3O4
Solubility: soluble in polar organic solvents
Quality control: NMR 1H, HPLC-MS, functional testing
Storage conditions: Storage: 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate.
MSDS: Download
Product specifications

Spectral properties

Excitation/absorption maximum, nm: 646
Emission maximum, nm: 662
CF260: 0.03
CF280: 0.04

Product citations

  1. Miltner, N.; Kalló, G.; Csősz, É.; Miczi, M.; Nagy, T.; Mahdi, M.; Mótyán, J. A.; Tőzsér, J. Identification of SARS-CoV-2 Main Protease (Mpro) Cleavage Sites Using Two-Dimensional Electrophoresis and In Silico Cleavage Site Prediction. International Journal of Molecular Sciences, 2023, 24(4), 3236. doi: 10.3390/ijms24043236
  2. Ryabchevskaya, E. M.; Granovskiy, D. L.; Evtushenko, E. A.; Ivanov, P. A.; Kondakova, O. A.; Nikitin, N. A.; Karpova, O. V. Designing Stable Bacillus Anthracis Antigens with a View to Recombinant Anthrax Vaccine Development. Pharmaceutics, 2022, 14(4), 806. doi: 10.3390/pharmaceutics14040806
  3. Yu, W.; Bosquée, E.; Fan, J.; Liu, Y.; Bragard, C.; Francis, F.; Chen, J. Proteomic and Transcriptomic Analysis for Identification of Endosymbiotic Bacteria Associated with BYDV Transmission Efficiency by Sitobion miscanthi. Plants, 2022, 11(23), 3352. doi: 10.3390/plants11233352
  4. Pletnev, P. I.; Shulenina, O.; Evfratov, S.; Treshin, V.; Subach, M. F.; Serebryakova, M. V.; Osterman, I. A.; Paleskava, A.; Bogdanov, A. A.; Dontsova, O. A.; Konevega, A. L.; Sergiev, P. V. Ribosomal Protein S18 Acetyltransferase RimI Is Responsible for the Acetylation of Elongation Factor Tu. Journal of Biological Chemistry, 2022, 298(5), 101914. doi: 10.1016/j.jbc.2022.101914
Show more (42)

Cy® is a trademark of GE Healthcare.

Purchase of these products does not imply transfer of license to perform methods patented by Carnegie Mellon University covered by US patents 6,043,025, 6,127,134, 6,246,190, 7566,544, and 7,598,047 "Difference gel electrophoresis using matched multiple dyes" and family members in Australia, Canada, Europe and Japan.

This Product is offered and sold for research purposes only. It has not been tested for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. Supply does not express or imply authorization to use for any other purpose, including, without limitation, in vitro diagnostic purposes, in the manufacture of food or pharmaceutical products, in medical devices or in cosmetic products.
Your item has been added. View your cart or proceed to checkout
The count of items is incorrect.